PATIENT: PT-2024-001 (SYNTHETIC - NOT REAL)
DOCUMENT TYPE: MD Oncology Note — Initial Visit
VISIT NUMBER: 1
DATE: 2024-03-01
PHYSICIAN: Dr. Amanda Singh (SYNTHETIC)
SPECIALTY: Medical Oncology

HISTORY OF PRESENT ILLNESS:
52-year-old female presenting for oncology evaluation
following biopsy confirmed left breast invasive
ductal carcinoma. Patient noticed lump 6 weeks ago.
No prior breast cancer history. No prior biopsies.

FAMILY HISTORY:
Mother — breast cancer diagnosed age 58
Maternal aunt — ovarian cancer diagnosed age 63
Father — hypertension, type 2 diabetes

PAST MEDICAL HISTORY:
1. Hypertension — diagnosed 2019, well controlled
2. Hypothyroidism — diagnosed 2020, on levothyroxine
3. Anxiety disorder — diagnosed 2018

MEDICATIONS:
1. Lisinopril 5mg daily — hypertension
2. Levothyroxine 50mcg daily — hypothyroidism
3. Sertraline 50mg daily — anxiety

ALLERGIES: Penicillin (rash)

SOCIAL HISTORY:
Non-smoker. Occasional alcohol (1-2 drinks/week).
Married, two children. Works as a teacher.

REVIEW OF SYSTEMS:
No bone pain. No shortness of breath.
No neurological symptoms. No weight loss.
Mild fatigue noted.

PHYSICAL EXAMINATION:
ECOG Performance Status: 0
Left breast: Palpable 2cm irregular mass,
upper outer quadrant. Mobile. Non-tender.
Left axilla: Two palpable lymph nodes, firm, mobile.
Right breast: No masses palpable.
No hepatomegaly. No splenomegaly.

STAGING WORKUP ORDERED:
PET-CT whole body
MRI left breast bilateral
Bone scan
CT chest/abdomen/pelvis
Echocardiogram (baseline prior to chemotherapy)

ASSESSMENT:
Invasive Ductal Carcinoma, Left Breast
ER+, PR+, HER2-
Clinical staging: cT2 N1 M0 — Stage IIA/IIB pending
full staging workup

GERMLINE TESTING:
Given family history (mother breast cancer, aunt
ovarian cancer) — BRCA1/BRCA2 germline testing
strongly recommended. Patient consented.
Blood sent to lab.

PLAN:
1. Complete staging workup as above
2. Multidisciplinary tumor board discussion
3. Neoadjuvant chemotherapy likely given grade 3,
   Ki-67 35%, node positive disease
4. Probable regimen: AC-T (Adriamycin/Cyclophosphamide
   followed by Taxol)
5. Genetic counseling referral placed
6. Follow up in 2 weeks with staging results

PHYSICIAN SIGNATURE: Dr. Amanda Singh (SYNTHETIC)